HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masafumi Kawanishi Selected Research

4- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochloride

9/2009NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects.
9/2007NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masafumi Kawanishi Research Topics

Disease

1Rheumatoid Arthritis
11/2022
1Asthma (Bronchial Asthma)
09/2009
1Respiratory Hypersensitivity
09/2009
1Peripheral Arterial Disease
09/2007
1Intermittent Claudication
09/2007

Drug/Important Bio-Agent (IBA)

24- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochlorideIBA
09/2009 - 09/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022
1Methotrexate (Mexate)FDA LinkGeneric
11/2022
1OvalbuminIBA
09/2009
1Phosphodiesterase InhibitorsIBA
09/2007
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
09/2007
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2007

Therapy/Procedure

1Therapeutics
11/2022